New indications for direct thrombin inhibitors

Details New indications for direct thrombin inhibitors New indications for direct thrombin inhibitors

A - Human Necessities

61

K

A61K 31/397 (2006.01) A61K 31/4184 (2006.01) A61K 31/4439 (2006.01) A61K 31/4709 (2006.01) A61K 38/58 (2006.01) A61P 7/02 (2006.01) A61P 9/14 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2657269

The invention relates to new indications for direct thrombin inhibitors such as dabigatran etexilate in the CNS and other fields.

La présente invention porte sur de nouvelles indications relatives aux inhibiteurs directs de la thrombine, tels que le dabigatran etexilate, dans le domaine du système nerveux central et d'autres domaines.

Affiliated with

Also associated with

Rating

New indications for direct thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New indications for direct thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New indications for direct thrombin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2059107